Cell surface expression of the checkpoint protein programmed death ligand 1 (PD-L1, also named B7-H1 and CD274) is a potent mechanism of immune evasion employed by a wide variety of tumor types and is the target of several checkpoint blockade immunotherapies for cancer [1]. The gene discussed is CD274; the disease is cancer.